Arkolith/Insider Trading/GLUE/Form 4

Warmuth Markus

President & CEO, DirectorMonte Rosa Therapeutics, Inc. (GLUE) · full profile →Form 4 · filed Jan 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$128K
Net Open-Market Flow
-$128K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2026Sell(S)309$24.57$8K619K
Jan 7, 2026Sell(S)1K$23.88$35K619K
Jan 7, 2026Sell(S)4K$23.24$86K621K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-008902) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML